Company Quick10K Filing
Tropic International
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 58 $86
10-Q 2020-01-22 Quarter: 2019-11-30
10-K 2019-12-02 Annual: 2019-08-31
10-Q 2019-07-16 Quarter: 2019-05-31
10-Q 2019-04-19 Quarter: 2019-02-28
10-Q 2019-01-18 Quarter: 2018-11-30
10-K 2018-12-14 Annual: 2018-08-31
10-Q 2018-07-19 Quarter: 2018-05-31
10-Q 2018-04-19 Quarter: 2018-02-28
10-Q 2018-01-22 Quarter: 2017-11-30
10-K 2017-12-15 Annual: 2017-08-31
10-Q 2017-07-19 Quarter: 2017-05-31
10-Q 2017-04-17 Quarter: 2017-02-28
10-Q 2017-01-19 Quarter: 2016-11-30
10-K 2016-12-14 Annual: 2016-08-31
10-Q 2016-07-15 Quarter: 2016-05-31
10-Q 2016-04-14 Quarter: 2016-02-29
10-Q 2016-01-14 Quarter: 2015-11-30
10-K 2015-11-30 Annual: 2015-08-31
10-Q 2015-07-13 Quarter: 2015-05-31
10-Q 2015-04-14 Quarter: 2015-02-28
10-Q 2015-01-13 Quarter: 2014-11-30
10-K 2014-11-28 Annual: 2014-08-31
10-Q 2014-07-15 Quarter: 2014-05-31
10-Q 2014-04-18 Quarter: 2014-02-28
10-Q 2014-01-14 Quarter: 2013-11-30
10-K 2013-12-09 Annual: 2013-08-31
10-Q 2013-06-20 Quarter: 2013-04-30
10-Q 2013-03-18 Quarter: 2013-01-31
10-K 2013-01-29 Annual: 2012-10-31
10-Q 2012-09-19 Quarter: 2012-07-31
10-Q 2012-06-21 Quarter: 2012-04-30
10-Q 2012-03-21 Quarter: 2012-01-31
10-K 2012-02-13 Annual: 2011-10-31
10-Q 2011-09-16 Quarter: 2011-07-31
10-Q 2011-06-20 Quarter: 2011-04-30
10-Q 2011-04-14 Quarter: 2011-01-31
10-K 2011-03-28 Annual: 2010-10-31
8-K 2019-12-01 Enter Agreement, Exhibits
8-K 2019-07-19 Enter Agreement
8-K 2019-03-29 Accountant, Exhibits
8-K 2018-12-27 Other Events
8-K 2018-12-07 Other Events
8-K 2018-11-19 Amend Bylaw, Other Events, Exhibits

Tropic International Financials

TRPO Metrics, Comps, Filings

Annual | Quarterly

Business

We are a company in the business of developing and commercializing innovative technologies. Through Notox, we own 100% of the right, title and interest in and to the License Agreement with the Clinic formerly held by ZHC. The License Agreement grants us the exclusive license to certain patented intellectual property of the Clinic relating to the treatment of a neuromuscular defect developed by Dr. Frank Papay, MD, FACS Chairman Dermatology and Plastic Surgery Institute, Cleveland Clinic, and in particular, the ability to produce, sell, improve and modernize products that incorporate such intellectual property in the fields of aesthetics, drug free pain management, body contouring and perspiration control. We plan to develop this intellectual property into the world's first credible and healthier non-toxic alternative to Botox, which is a commercial form of the botulinum toxin protein used primarily for medical and cosmetic purposes.

Through Tropic Spa, we have finalized the design of a personal tanning product and applied for and acquired patents for it in the United States (the “US Patent”), Canada, Australia and China. The product consists of a unique tanning system designed for spas, gyms, clinics and convenient home use that delivers a full-body application and eliminates the harmful health effects associated with traditional tanning beds, and in particular, exposure to ultraviolet (UV) radiation. We are currently seeking to establish licensing opportunities for Tropic Spa's intellectual property, but have not entered into any formal arrangements as of the date of this Report.

We were incorporated as “Rockford Minerals Inc.” under the laws of the State of Nevada on October 29, 2007. From our inception until the closing of the Share Exchange, we sought to be a producer of gold and silver ore, and of other precious metals. On July 19, 2008, we acquired an undeveloped mining claim called the Rockford Lode Mining Claim located in Clark County, Nevada, for which we paid $12,000, including the cost of a geological report prepared by Sookochoff Consultants Inc. and Laurence Sookochoff, P. Eng., as a consulting geologist, for the purpose of recommending an exploration program. Due to lack of capital, we did not commence any phase of the exploration program recommended in the geological report.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Eaco (EACO) 95,530 38% 5.8 10% 92,878 41,688 161,185 61,233 9,432 16,498 96,297
Ammo (POWW) 78,693 -25% -6.2 -34% 46,021 20,194 7,742 -1,934 -15,634 -12,636 78,179
ChoiceOne Financial Services (COFS) 94,691 0% 8.1 1% 663,589 578,963 3,629 0 5,973 9,668 78,117
Invuity (IVTY) 92,683 67% -2.9 -75% 48,729 46,397 40,834 27,211 -36,461 -31,788 93,415
Nobility Homes (NOBH) 92,404 28% 9.0 11% 55,980 7,733 35,568 10,061 5,899 7,955 71,257
Aerkomm (AKOM) 94,280 1% -11.7 -17% 51,277 3,924 1,600 13 -8,941 -7,810 91,529
NCL (NCLC) 90,687 0% 4.3 6% 15,931,783 9,700,324 6,385,388 0 973,844 1,432,690 6,107,285
Humanigen (HGEN) 90,224 -12.4 -1,392% 594 13,260 0 0 -8,268 -7,265 89,996
Fuse Medical (FZMD) 88,479 42% -23.1 -26% 18,157 20,920 15,563 6,576 -4,717 -3,781 87,448
Mattersight (MATR) 89,019 72% -20.5 -39% 28,863 32,587 50,383 36,274 -11,234 -4,549 93,093
Sunnova Energy (NOVA) 709,370 0% -25.1 -4% 2,149,786 1,366,648 71,227 0 -84,176 -70,803 1,775,872
Tropic International (TRPO) 86,438 -136.1 -55% 1,160 3,987 0 0 -635 -635 86,423
Repro Med Systems (REPR) 148,883 64% 210.8 2% 13,717 2,708 21,211 13,620 289 682 143,754
Liberated Syndication (LSYN) 85,599 86% 13.7 7% 42,855 13,372 18,203 15,621 3,195 5,639 77,064
Community Bancorp (CMTV) 84,437 5.3 1% 729,232 661,911 0 0 8,596 15,952 84,437
Helix TCS (HLIX) 65,696 44% -12.3 -12% 74,083 7,816 11,011 4,865 -8,865 -5,311 65,477
Asia Pacific Boiler (PADR) 81,375 -130.3 -15,938% 4 1,600 0 0 -624 -624 81,375
Cannapharmarx (CPMD) 90,342 -12.2 -50% 22,468 9,856 0 0 -11,137 -7,963 97,149
Parkway Acquisition (PKKW) 78,794 3.6 1% 695,180 615,321 0 0 5,434 10,346 37,602
Intrusion (INTZ) 69,323 61% 15.6 62% 6,764 3,494 11,071 6,732 4,169 4,305 67,212

Balance Sheet ($'000)2011-10-312012-10-312013-08-312014-08-312015-08-312016-08-312017-08-312018-08-312019-08-31
Cash3111218814563615
Accounts Receivable
Inventory16914813112200
PP&E184735343340
Assets315,2374,7374,3214,2971,5231,2271,160
Accounts Payable243138682807529301,4121,193
Long-Term Debt
Liabilities6238633897181,2813,5093,5343,987
Stockholders' Equity-59-375,1754,3483,6043,017-1,986-2,307-2,827
Income Statement ($'000)2011-10-312012-10-312013-08-312014-08-312015-08-312016-08-312017-08-312018-08-312019-08-31
Revenue7351000
Cost of Revenue
Gross Profit
R&D
SG&A1425438414357607617804753
Tax000000000
Net Income-62-69-782-826-775-1,030-5,072-811-635
Cash Flow ($'000)2011-10-312012-10-312013-08-312014-08-312015-08-312016-08-312017-08-312018-08-312019-08-31
Cash Operating-52-53-451-389-136-169-592-112-155
Cash Investing-24-12-6-15-6660-154
Cash Financing38515523081323201,17655318